Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimegepant for Acute Migraine in Chinese and Korean Patients
NCT04574362Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of rimegepant in migraine, sponsored by Pfizer. Started Oct 2020; status: completed.
02
Drugs
rimegepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04574362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04574362.